(2-Methyl-4-(pyrrolidin-1-ylsulfonyl)phenyl)boronic acid, 95.0%, 250mg

4-Chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide, 97%, 250mg

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 15 m, Ø-Innen 0,25 mm, Filmd. 0,10 µm, 1 Stück

6-Fluoro-2-methyl-1,2,3,4-tetrahydroquinoline, 97.0%, 10g

(2S,3R)-2-methylpiperidine-3-carboxylic acid, 98%, 500mg

Hex-4-yn-2-amine, 98%, 250mg

Velnacrine, 95.0%, 250mg

3-Hydroxy-2-nitrobenzoic acid, 98.0%, 5g

N-Trimethylsilylimidazole [Trimethylsilylating Reagent]>98.0%(T)25g

Bromoterephthalic Acid>98.0%(GC)5g

3-Ethynylpyridine>98.0%(GC)(T)1g

2-(S-Methylsulfonimidoyl)thiazole, 1g

2'-Methylacetoacetanilide>98.0%(HPLC)(N)25g